Novo Nordisk Looks to Target Hair Loss in Consumer Push
The maker of Ozempic and Wegovy seeks to expand its direct-to-consumer pharmaceutical business as rival Eli Lilly outpaces in weight-loss drugs.
The Business of Beauty
In-depth analysis, news and advice for beauty and wellness professionals around the world.
Highlights
Loading highlights…
Case Studies & Reports
Latest News & Analysis
The Korean Challenger Taking on Global Giants
Goodai is the latest indie breakout to toy with trading in the public markets.
Can Beauty Save Shein?
The beauty brand Sheglam has ambitions to become as big as its fast-fashion parent, if not bigger. Just don’t call it a ‘dupe’ brand.
The Tween Beauty Story Is Tired. Can We Move On?
This week, Priya Rao argues that Gen Alpha’s interest in cosmetics and skincare mirrors that of its predecessors,
Who Has a Right to Win in Fragrance?
Beauty brands, major conglomerates and indie labels see perfume as an opportunistic venture for growth. But as category sales moderate, can new scents and players break through?
ADVERTISEMENT
Victoria’s Secret Brought Sexy Back. What About Beauty?
The underwear juggernaut has been hard at work revitalising its offer by returning to its glamorous roots. But its massive cosmetics and fragrance business has been slower to transform.
A Decade After Mercury Ban, Toxic Skin Bleachers Still Abound
More than 20 banned skin-bleaching products containing mercury are available on Amazon, Temu and TikTok Shop in several countries, despite decades of efforts to prevent their sale.
C-Beauty’s Global Moment Is Now
From Proya to Florasis, Chinese beauty brands are looking for opportunities abroad amid an uneven domestic market. Retailers around the world are eager to stock them.
Why Beauty Loves Abbey Yung
Influencer and certified trichologist Yung has turned hair-care expertise and accessible advice into a lucrative career, wherein trust is her biggest asset — and liability.
ADVERTISEMENT
Colgate-Palmolive Seeks to Divest Personal Care Brands
The consumer goods giant is exploring a sale of mass-market brands including Softsoap, Irish Spring and Speed Stick, that together could fetch over $1 billion, sources told Reuters.
How a UK Hairstylist Brought Black Hair Into the Global Spotlight
A new exhibition in London celebrates Charlotte Mensah, whose clients include Janelle Monáe and Zadie Smith and who is on a mission to ensure stylists are trained to work with all hair types.
The Case for Fun Luxury Makeup
Lara Worthington’s new luxury makeup label Ommage, which lands at Dover Street Parfums Market this month, hopes to bring a playful touch to upscale beauty routines.
The 5 Reasons Why Beauty Has Never Been Tougher
This week, Priya Rao contemplates beauty’s latest disruptions.
THE NEWS IN BRIEF
PR Agency CGC Launches Performance Media Division
Known for its premium beauty clients including Glossier and Hermès Beauty, the agency’s new division combines influencer marketing and AI insights.
Luxury Perfume Line Roja London Acquired by Extravaganza Beauty
Master perfumer and founder Roja Dove will remain with the brand in a new consultancy role.
Olaplex Names New CEO
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.
Perelel Expands C-Suite, Tapping Rare Beauty’s CMO
Known for its prenatal vitamins, the wellness label has hired Rare Beauty's Ashley Murphy as its chief marketing officer, while Anjelika Temple moves into the chief creative officer role.
Supergoop Announces Chief Commercial Officer
The sunscreen label has appointed former Coty executive Jamie Parker to the newly created role as it gears up to become a “global skin health company.”
L’Oréal Steals French Stock Market Crown From LVMH
The cosmetics group became France’s most valuable listed company on Tuesday, the first time since 2017 that a non-luxury company has claimed the top spot at the end of a trading day.
Kimberly-Clark Prepares Asset Sales to Win EU Nod for Kenvue Deal
The US consumer goods giant is preparing concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal, sources told Reuters.